IDH1 and central nervous system cancer: Research showed different molecular markers in tumors between children and adults, with pediatric low-grade gliomas predominantly exhibiting alterations in the BRAF, FGFR, and MYB/MYBL1 genes, while IDH1/2 mutations were less common [50].